Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 1/2022

01.09.2022 | Original Article

Interplay of tau and functional network connectivity in progressive supranuclear palsy: a [18F]PI-2620 PET/MRI study

verfasst von: Gayane Aghakhanyan, M. Rullmann, J. Rumpf, M. L. Schroeter, C. Scherlach, M. Patt, M. Brendel, N. Koglin, A. W. Stephens, J. Classen, K. T. Hoffmann, O. Sabri, H. Barthel

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Progressive supranuclear palsy (PSP) is primary 4-repeat tauopathy. Evidence spanning from imaging studies indicate aberrant connectivity in PSPs. Our goal was to assess functional connectivity network alterations in PSP patients and the potential link between regional tau-burden and network-level functional connectivity using the next-generation tau PET tracer [18F]PI-2620 and resting-state functional MRI (fMRI).

Material and methods

Twenty-four probable PSP patients (70.9 ± 6.9 years, 13 female), including 14 Richardson syndrome (RS) and 10 non-RS phenotypes, underwent [18F]PI-2620 PET/MRI imaging. Distribution volume ratios (DVRs) were estimated using non-invasive pharmacokinetic modeling. Resting-state fMRI was also acquired in these patients as well as in thirteen older non-AD MCI reference group (64 ± 9 years, 4 female). The functional network was constructed using 141 by 141 region-to-region functional connectivity metrics (RRC) and network-based statistic was carried out (connection threshold p < 0.001, cluster threshold pFDR < 0.05).

Results

In total, 9870 functional connections were analyzed. PSPs compared to aged non-AD MCI reference group expressed aberrant connectivity evidenced by the significant NBS network consisting of 89 ROIs and 118 connections among them (NBS mass 4226, pFDR < 0.05). Tau load in the right globus pallidus externus (GPe) and left dentate nucleus (DN) showed significant effects on functional network connectivity. The network linked with increased tau load in the right GPe was associated with hyperconnectivity of low-range intra-opercular connections (NBS mass 356, pFDR < 0.05), while the network linked with increased tau load in the left cerebellar DN was associated with cerebellar hyperconnectivity and cortico-cerebellar hypoconnectivity (NBS mass 517, pFDR < 0.05).

Conclusions

PSP patients show altered functional connectivity. Network incorporating deep gray matter structures demonstrate hypoconnectivity, cerebellum hyperconnectivity, while cortico-cortical connections show variable changes. Tau load in the right GPe and left DN is associated with functional networks which strengthen low-scale intra-opercular and intra-cerebellar connections and weaken opercular-cerebellar connections. These findings support the concept of tau load-dependent functional network changes in PSP, by that providing evidence for downstream effects of neuropathology on brain functionality in this primary tauopathy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Goedert M, Spillantini MG. Pathogenesis of the tauopathies. J Mol Neurosci: MN. 2011;45:425–31.CrossRefPubMed Goedert M, Spillantini MG. Pathogenesis of the tauopathies. J Mol Neurosci: MN. 2011;45:425–31.CrossRefPubMed
3.
Zurück zum Zitat Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8:270–9.CrossRefPubMed Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8:270–9.CrossRefPubMed
4.
Zurück zum Zitat Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord: Off J Mov Disord Soc. 2017;32:853–64.CrossRef Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord: Off J Mov Disord Soc. 2017;32:853–64.CrossRef
5.
Zurück zum Zitat Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, et al. Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Mov Disord: Off J Mov Disord Soc. 2017;32:955–71.CrossRef Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, et al. Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Mov Disord: Off J Mov Disord Soc. 2017;32:955–71.CrossRef
6.
Zurück zum Zitat Albrecht F, Bisenius S, Neumann J, Whitwell J, Schroeter ML. Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy – a double-validation whole-brain meta-analysis. NeuroImage: Clinical. 2019;22:101722.CrossRef Albrecht F, Bisenius S, Neumann J, Whitwell J, Schroeter ML. Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy – a double-validation whole-brain meta-analysis. NeuroImage: Clinical. 2019;22:101722.CrossRef
7.
Zurück zum Zitat Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Brendel E, Prix C, et al. Clinical routine FDG-PET imaging of suspected progressive supranuclear palsy and corticobasal degeneration: a gatekeeper for subsequent tau-PET imaging? Front Neurol. 2018;9:483.CrossRefPubMedPubMedCentral Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Brendel E, Prix C, et al. Clinical routine FDG-PET imaging of suspected progressive supranuclear palsy and corticobasal degeneration: a gatekeeper for subsequent tau-PET imaging? Front Neurol. 2018;9:483.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Zhao P, Zhang B, Gao S, Li X. Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy. J Clin Neurosci. 2020;80:318–23.CrossRefPubMed Zhao P, Zhang B, Gao S, Li X. Clinical, MRI and 18F-FDG-PET/CT analysis of progressive supranuclear palsy. J Clin Neurosci. 2020;80:318–23.CrossRefPubMed
9.
Zurück zum Zitat Bharti K, Bologna M, Upadhyay N, Piattella MC, Suppa A, Petsas N, et al. Abnormal resting-state functional connectivity in progressive supranuclear palsy and corticobasal syndrome. Front Neurol. 2017;8:1247.CrossRef Bharti K, Bologna M, Upadhyay N, Piattella MC, Suppa A, Petsas N, et al. Abnormal resting-state functional connectivity in progressive supranuclear palsy and corticobasal syndrome. Front Neurol. 2017;8:1247.CrossRef
10.
Zurück zum Zitat Piattella MC, Tona F, Bologna M, Sbardella E, Formica A, Petsas N, et al. Disrupted resting-state functional connectivity in progressive supranuclear palsy. Am J Neuroradiol. 2015;36:915–21.CrossRefPubMedPubMedCentral Piattella MC, Tona F, Bologna M, Sbardella E, Formica A, Petsas N, et al. Disrupted resting-state functional connectivity in progressive supranuclear palsy. Am J Neuroradiol. 2015;36:915–21.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Whitwell JL, Avula R, Master A, Vemuri P, Senjem ML, Jones DT, et al. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord. 2011;17:599–605.CrossRefPubMedPubMedCentral Whitwell JL, Avula R, Master A, Vemuri P, Senjem ML, Jones DT, et al. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord. 2011;17:599–605.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci. 2009;10:186–98.CrossRefPubMed Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci. 2009;10:186–98.CrossRefPubMed
13.
Zurück zum Zitat Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol. 2020;140:99–119 (Springer Berlin Heidelberg).CrossRefPubMedPubMedCentral Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol. 2020;140:99–119 (Springer Berlin Heidelberg).CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Smith SM, Vidaurre D, Beckmann CF, Glasser MF, Jenkinson M, Miller KL, et al. Functional connectomics from resting-state fMRI. Trends Cogn Sci. 2013;17:666–82.CrossRefPubMedPubMedCentral Smith SM, Vidaurre D, Beckmann CF, Glasser MF, Jenkinson M, Miller KL, et al. Functional connectomics from resting-state fMRI. Trends Cogn Sci. 2013;17:666–82.CrossRefPubMedPubMedCentral
15.
17.
Zurück zum Zitat Kroth H, Oden F, Molette J, Schieferstein H, Capotosti F, Mueller A, et al. Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies. Eur J Nucl Med Mol Imaging. 2019;46:2178–89.CrossRefPubMedPubMedCentral Kroth H, Oden F, Molette J, Schieferstein H, Capotosti F, Mueller A, et al. Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies. Eur J Nucl Med Mol Imaging. 2019;46:2178–89.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain. 2007;130:1552–65.CrossRefPubMed Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain. 2007;130:1552–65.CrossRefPubMed
20.
Zurück zum Zitat Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson’s disease. In: Billingham FH, Donaldson MC, editors. Third symposium on Parkinson’s disease. Edinburgh: Churchill Livingstone; 1969. p. 152–7. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson’s disease. In: Billingham FH, Donaldson MC, editors. Third symposium on Parkinson’s disease. Edinburgh: Churchill Livingstone; 1969. p. 152–7.
21.
Zurück zum Zitat Guy W. ECDEU assessment manual for psychopharmacology, Revised. US Department of Health, Education, and Welfare Publication (ADM). Rockville: National Institute of Mental Health. 1976. p. 76–338. Guy W. ECDEU assessment manual for psychopharmacology, Revised. US Department of Health, Education, and Welfare Publication (ADM). Rockville: National Institute of Mental Health. 1976. p. 76–338.
22.
Zurück zum Zitat Ladefoged CN, Law I, Anazodo U, St Lawrence K, Izquierdo-Garcia D, Catana C, et al. A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients. Neuroimage. 2017;147:346–59.CrossRefPubMed Ladefoged CN, Law I, Anazodo U, St Lawrence K, Izquierdo-Garcia D, Catana C, et al. A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients. Neuroimage. 2017;147:346–59.CrossRefPubMed
23.
Zurück zum Zitat Makris N, Goldstein JM, Kennedy D, Hodge SM, Caviness VS, Faraone SV, Tsuang MT, Seidman LJ. Decreased volume of left and total anterior insular lobule in schizophrenia. Schizophr Res. 2006;83(2–3):155–71.CrossRefPubMed Makris N, Goldstein JM, Kennedy D, Hodge SM, Caviness VS, Faraone SV, Tsuang MT, Seidman LJ. Decreased volume of left and total anterior insular lobule in schizophrenia. Schizophr Res. 2006;83(2–3):155–71.CrossRefPubMed
24.
Zurück zum Zitat Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Étard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273–89.CrossRefPubMed Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Étard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273–89.CrossRefPubMed
26.
Zurück zum Zitat Diedrichsen J, Balsters JH, Flavell J, Cussans E, Ramnani N. A probabilistic MR atlas of the human cerebellum. NeuroImage. 2009;46:39–46 (Elsevier B.V.).CrossRefPubMed Diedrichsen J, Balsters JH, Flavell J, Cussans E, Ramnani N. A probabilistic MR atlas of the human cerebellum. NeuroImage. 2009;46:39–46 (Elsevier B.V.).CrossRefPubMed
27.
Zurück zum Zitat Ichise M, Liow J-S, Lu J-Q, Takano A, Model K, Toyama H, et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003;23:1096–112.CrossRefPubMed Ichise M, Liow J-S, Lu J-Q, Takano A, Model K, Toyama H, et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab. 2003;23:1096–112.CrossRefPubMed
28.
Zurück zum Zitat Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2:125–41.CrossRefPubMed Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2:125–41.CrossRefPubMed
29.
Zurück zum Zitat Zalesky A, Fornito A, Bullmore ET. Network-based statistic: identifying differences in brain networks. NeuroImage. 2010;53:1197–207 (Elsevier Inc.).CrossRefPubMed Zalesky A, Fornito A, Bullmore ET. Network-based statistic: identifying differences in brain networks. NeuroImage. 2010;53:1197–207 (Elsevier Inc.).CrossRefPubMed
30.
Zurück zum Zitat Gardner RC, Boxer AL, Trujillo A, Mirsky JB, Guo CC, Gennatas ED, et al. Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann Neurol. 2013;73:603–16.CrossRefPubMedPubMedCentral Gardner RC, Boxer AL, Trujillo A, Mirsky JB, Guo CC, Gennatas ED, et al. Intrinsic connectivity network disruption in progressive supranuclear palsy. Ann Neurol. 2013;73:603–16.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Rosskopf J, Gorges M, Müller H-P, Lulé D, Uttner I, Ludolph AC, et al. Intrinsic functional connectivity alterations in progressive supranuclear palsy: differential effects in frontal cortex, motor, and midbrain networks. Mov Disord: Off J Mov Disord Soc. 2017;32:1006–15.CrossRef Rosskopf J, Gorges M, Müller H-P, Lulé D, Uttner I, Ludolph AC, et al. Intrinsic functional connectivity alterations in progressive supranuclear palsy: differential effects in frontal cortex, motor, and midbrain networks. Mov Disord: Off J Mov Disord Soc. 2017;32:1006–15.CrossRef
32.
Zurück zum Zitat Warren JD, Rohrer JD, Schott JM, Fox NC, Hardy J, Rossor MN. Molecular nexopathies: a new paradigm of neurodegenerative disease. Trends Neurosci. 2013;36:561–9.CrossRefPubMedPubMedCentral Warren JD, Rohrer JD, Schott JM, Fox NC, Hardy J, Rossor MN. Molecular nexopathies: a new paradigm of neurodegenerative disease. Trends Neurosci. 2013;36:561–9.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Abos A, Segura B, Baggio HC, Campabadal A, Uribe C, Garrido A, et al. Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy. Neuroimage Clin. 2019;23:101899.CrossRefPubMedPubMedCentral Abos A, Segura B, Baggio HC, Campabadal A, Uribe C, Garrido A, et al. Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy. Neuroimage Clin. 2019;23:101899.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Piao Y-S, Hayashi S, Wakabayashi K, Kakita A, Aida I, Yamada M, et al. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 2002;103:469–74.CrossRefPubMed Piao Y-S, Hayashi S, Wakabayashi K, Kakita A, Aida I, Yamada M, et al. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 2002;103:469–74.CrossRefPubMed
37.
Zurück zum Zitat Cope TE, Rittman T, Borchert RJ, Jones PS, Vatansever D, Allinson K, et al. Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy. Brain. 2018;141:550–67.CrossRefPubMedPubMedCentral Cope TE, Rittman T, Borchert RJ, Jones PS, Vatansever D, Allinson K, et al. Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy. Brain. 2018;141:550–67.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Barthel H. First tau PET tracer approved: toward accurate in vivo diagnosis of Alzheimer disease. J Nucl Med. 2020;61:1409–10.CrossRefPubMed Barthel H. First tau PET tracer approved: toward accurate in vivo diagnosis of Alzheimer disease. J Nucl Med. 2020;61:1409–10.CrossRefPubMed
41.
Zurück zum Zitat Rytty R, Nikkinen J, Paavola L, Abou Elseoud A, Moilanen V, Visuri A, Tervonen O, Renton AE, Traynor BJ, Kiviniemi V, Remes AM. GroupICA dual regression analysis of resting state networks in a behavioral variant of frontotemporal dementia. Front Hum Neurosci. 2013;7:461. https://doi.org/10.3389/fnhum.2013.00461. Rytty R, Nikkinen J, Paavola L, Abou Elseoud A, Moilanen V, Visuri A, Tervonen O, Renton AE, Traynor BJ, Kiviniemi V, Remes AM. GroupICA dual regression analysis of resting state networks in a behavioral variant of frontotemporal dementia. Front Hum Neurosci. 2013;7:461. https://​doi.​org/​10.​3389/​fnhum.​2013.​00461.
Metadaten
Titel
Interplay of tau and functional network connectivity in progressive supranuclear palsy: a [18F]PI-2620 PET/MRI study
verfasst von
Gayane Aghakhanyan
M. Rullmann
J. Rumpf
M. L. Schroeter
C. Scherlach
M. Patt
M. Brendel
N. Koglin
A. W. Stephens
J. Classen
K. T. Hoffmann
O. Sabri
H. Barthel
Publikationsdatum
01.09.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2022
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-05952-0

Weitere Artikel der Ausgabe 1/2022

European Journal of Nuclear Medicine and Molecular Imaging 1/2022 Zur Ausgabe